Multiplex that matters: Considerations for maximizing the impact of multiplex respiratory assays

Many laboratories are redefining their respiratory testing algorithms to meet patient needs in an unpredictable, post-pandemic era.

Hear from two experts at UC Davis Health on their considerations for implementing multiplex respiratory PCR solutions across diverse patient settings within their health network. Both provide examples of the impacts they have observed on patient management.

Panelists:
Nam Tran, Ph.D., HCLD (ABB), FACB, UC Davis Health
Larissa May, M.D., MSPH, MSHS, UC Davis Health

Moderator:
Tiffeny Smith, PharmD, BCIDP, Roche Diagnostics

0:00 Introductions
3:13 Understanding the benefit of multiplex respiratory testing for laboratories
12:36 Impact of implementing multiplex respiratory assays
14:16 Implementing rapid molecular testing for clinicians
16:09 Why use molecular testing for respiratory tract infections
17:43 Applying the test-to-treat model
18:49 Implementing multiplex testing at UC Davis
25:31 Recommendations for multiplex testing
26:44 Q&A

#MultiplexTesting

MC-US-13825